Eyenovia’s HYPE Surge: Not Just Hype—It’s Strategy

Let’s be real: I don’t do emotional investing. But when a biotech company with \(56k in revenue bought \)50M worth of $HYPE tokens? I paused mid-ramen.

This isn’t gambling—it’s financial alchemy. A dying stock reborn as a DeFi vault shell game? Yes, please.

Enter Hyunsu Jung: Harvard grad, McKinsey veteran, ex-roommate of Hyperliquid’s co-founder. That’s not networking—that’s protocol bonding.

And now they’re staking HYPE, lending on AMMs, voting on HIP-3… all while pretending they’re still making eye drops.

If this is evolution, I’m upgrading my wallet.

You guys ready to see public companies paying dividends from staking rewards? 🤔

Drop your take below—this one’s gonna blow up (or at least get us some free yield).